home / stock / tals / tals quote
Last: | $2.72 |
---|---|
Change Percent: | -1.46% |
Open: | $2.78 |
Close: | $2.72 |
High: | $2.795 |
Low: | $2.69 |
Volume: | 299,250 |
Last Trade Date Time: | 10/19/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.72 | $2.78 | $2.72 | $2.795 | $2.69 | 299,250 | 10-19-2023 |
$2.74 | $2.84 | $2.74 | $2.84 | $2.6 | 430,014 | 10-18-2023 |
$2.82 | $3.01 | $2.82 | $3.05 | $2.75 | 277,436 | 10-17-2023 |
$3 | $3.1 | $3 | $3.13 | $2.91 | 236,260 | 10-16-2023 |
$2.86 | $2.75 | $2.86 | $3.04 | $2.67 | 628,040 | 10-13-2023 |
$2.7 | $2.69 | $2.7 | $2.7918 | $2.63 | 132,552 | 10-12-2023 |
$2.62 | $2.64 | $2.62 | $2.76 | $2.57 | 141,908 | 10-11-2023 |
$2.65 | $2.71 | $2.65 | $2.732 | $2.53 | 345,285 | 10-10-2023 |
$2.7 | $2.84 | $2.7 | $2.8699 | $2.67 | 332,561 | 10-09-2023 |
$2.7 | $2.68 | $2.7 | $2.74 | $2.59 | 112,964 | 10-06-2023 |
$2.68 | $2.67 | $2.68 | $2.75 | $2.65 | 26,340 | 10-05-2023 |
$2.69 | $2.67 | $2.69 | $2.76 | $2.6 | 46,852 | 10-04-2023 |
$2.61 | $2.6 | $2.61 | $2.71 | $2.6 | 28,648 | 10-03-2023 |
$2.59 | $2.85 | $2.59 | $2.85 | $2.59 | 145,876 | 10-02-2023 |
$2.81 | $2.85 | $2.81 | $2.89 | $2.81 | 36,729 | 09-29-2023 |
$2.85 | $2.8899 | $2.85 | $2.92 | $2.83 | 67,276 | 09-28-2023 |
$2.87 | $2.87 | $2.87 | $2.91 | $2.85 | 25,556 | 09-27-2023 |
$2.9 | $2.84 | $2.9 | $2.9 | $2.79 | 137,198 | 09-26-2023 |
$2.84 | $2.91 | $2.84 | $2.94 | $2.801 | 58,379 | 09-25-2023 |
$2.93 | $2.8 | $2.93 | $2.96 | $2.7 | 77,048 | 09-22-2023 |
News, Short Squeeze, Breakout and More Instantly...
Talaris Therapeutics Inc. Company Name:
TALS Stock Symbol:
NASDAQ Market:
Gainers Biocept, Inc. (NASDAQ: BIOC) shares surged 91.8% to $0.98 in pre-market trading after falling over 6% on Tuesday. Biocept recently filed ...
Combined Company to Trade on Nasdaq Under Ticker "TRML"Talaris Announces 1-for-10 Reverse Stock Split of Common Stock BOSTON, Oct. 17, 2023 (GLO...
Combined Company to Trade on Nasdaq Under Ticker “TRML” Talaris Announces 1-for-10 Reverse Stock Split of Common Stock BOSTON, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Talaris Therapeutics, Inc. (Nasdaq: TALS) (“Talaris”) today announced the results of the special...